Abstract
Background
Heart rate-corrected QT (QTc) interval is associated with increased risk for cardiovascular events and mortality among individuals with diabetes mellitus (DM). Little is known about the epidemiology of prolonged QTc among people with DM in resource-limited settings.
Methods
We conducted a cross-sectional study among adults with diabetes in ambulatory care at the Mbarara Regional Referral Hospital, from November 2018 to April 2019. Twelve-lead ECG recordings were performed on all participants. We collected clinical and laboratory data related to diabetes disease status and treatment control. We estimated QTc using Bazett’s formula and categorized it according to standardized sex-adjusted thresholds. Linear regression analysis was performed to identify correlates of QTc.
Results
We recruited 299 participants with a mean age of 50.1 years (SD±9.8) and mean HbA1c of 9.7 % (SD±2.6), and 69.6% were female. We detected prolonged and borderline QTc in 6.4% (19/299, 95% CI: 3.9–9.7%) and 23.4% (70/299, 95% CI: 18.7–28.6%) of participants, respectively. In multivariate models, factors associated with increasing QTc interval were mean arterial pressure (β=0.34; 95% CI: 0.07–0.63, p=0.019) and female sex (β=15.26; 95% CI: 7.58–22.94, p<0.001).
Conclusions
The prevalence of abnormal QTc among individuals in routine diabetes care in southwestern Uganda was high. Female sex and mean arterial pressure were correlated with QTc interval. Given these findings, future studies should explore the clinical impact of abnormal QTc in this patient population.
Similar content being viewed by others
References
Organization, W.H. Global report on diabetes: World Health Organization; 2016.
Schernthaner G, Lotan C, Baltadzhieva-Trendafilova E, Ceponis J, Clodi M, Ducena K, et al. Unrecognised cardiovascular disease in type 2 diabetes: is it time to act earlier? Cardiovasc Diabetol. 2018;17(1):145.
Cardoso CR, Salles GF, Deccache W. QTc interval prolongation is a predictor of future strokes in patients with type 2 diabetes mellitus. Stroke. 2003;34(9):2187–94.
Veglio M, Sivieri R, Chinaglia A, Scaglione L, Cavallo-Perin P. QT interval prolongation and mortality in type 1 diabetic patients: a 5-year cohort prospective study. Neuropathy Study Group of the Italian Society of the Study of Diabetes, Piemonte Affiliate. Diabetes Care. 2000;23(9):1381–3.
Okin PM, Devereux RB, Lee ET, Galloway JM, Howard BV, Strong Heart Study. Electrocardiographic repolarization complexity and abnormality predict all-cause and cardiovascular mortality in diabetes: the strong heart study. Diabetes. 2004;53(2):434–40.
Rossing P, Breum L, Major-Pedersen A, Sato A, Winding H, Pietersen A, et al. Prolonged QTc interval predicts mortality in patients with type 1 diabetes mellitus. Diabet Med. 2001;18(3):199–205.
Salles GF, Bloch KV, Cardoso CR. Mortality and predictors of mortality in a cohort of Brazilian type 2 diabetic patients. Diabetes Care. 2004;27(6):1299–305.
Li X, Ren H, Xu ZR, Liu YJ, Yang XP, Liu JQ. Prevalence and risk factors of prolonged QTc interval among Chinese patients with type 2 diabetes. Exp Diabetes Res. 2012;2012:1–6.
Veglio M, et al. Prevalence of increased QT interval duration and dispersion in type 2 diabetic patients and its relationship with coronary heart disease: a population-based cohort. J Intern Med. 2002;251(4):317–24.
Yang X-h, et al. The relationship between insulin sensitivity and heart rate-corrected QT interval in patients with type 2 diabetes. Diabetol Metab Syndr. 2017;9(1):69.
Sivieri R, Veglio M, Chinaglia A, Scaglione P, Cavallo-Perin P, For the Neuropathy Study Group of the Italian Society for the Study of Diabetes, Piemonte affiliate. Prevalence of QT prolongation in a type 1 diabetic population and its association with autonomic neuropathy. Diabet Med. 1993;10(10):920–4.
Migisha R, et al. Prevalence and correlates of cardiovascular autonomic neuropathy among patients with diabetes in Uganda: a hospital-based cross-sectional study. Glob Heart. 2020;15(1).
Goldenberg I, Moss AJ, Zareba W. QT interval: how to measure it and what is “normal”. J Cardiovasc Electrophysiol. 2006;17(3):333–6.
Ukpabi OJ, Onwubere BJ. QTc prolongation in Black diabetic subjects with cardiac autonomic neuropathy. Afr Health Sci. 2017;17(4):1092–100.
Mahwi TO, Hasan RM, Faraj HI. Incidence of QTc prolongation in type 2 diabetes mellitus and its relation to cardiac autonomic neuropathy. J Med J. 2014;48(2):102–11.
Magodoro IM, et al. Population prevalence and correlates of prolonged QT interval: cross-sectional, population-based study from rural Uganda. Glob Heart. 2018.
Tesfamariam B, Cohen RA. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Phys Heart Circ Phys. 1992;263(2):H321–6.
Fiorentini A, Perciaccante A, Valente R, Paris A, Serra P, Tubani L. The correlation among QTc interval, hyperglycaemia and the impaired autonomic activity. Auton Neurosci. 2010;154(1-2):94–8.
Wartenberg M, Ling FC, Schallenberg M, Bäumer AT, Petrat K, Hescheler J, et al. Down-regulation of intrinsic P-glycoprotein expression in multicellular prostate tumor spheroids by reactive oxygen species. J Biol Chem. 2001;276(20):17420–8.
Roden DM, Yang T. Protecting the heart against arrhythmias: potassium current physiology and repolarization reserve. 2005. Am Heart Assoc.
Satpathy S, Satpathy S, Nayak PK. Correlation of blood pressure and QT interval. Natl J Physiol Pharm Pharmacol. 2018;8(2):207–10.
Sun G-Z, Zhou Y, Ye N, Wu SJ, Sun YX. Independent influence of blood pressure on QTc interval: results from a general Chinese population. Biomed Res Int. 2019;2019:1–8.
Peng S, Yu Y, Hao K, Xing H, Li D, Chen C, et al. Heart rate–corrected QT interval duration is significantly associated with blood pressure in Chinese hypertensives. J Electrocardiol. 2006;39(2):206–10.
Matsumura K, et al. Association of QT interval with blood pressure in 80-year-old subjects. Hypertens Res. 2004;27(6):387–91.
Klimas J, Stankovicova T, Kyselovic J, Bacharova L. Prolonged QT interval is associated with blood pressure rather than left ventricular mass in spontaneously hypertensive rats. Clin Exp Hypertens. 2008;30(7):475–85.
Oikarinen L, Nieminen MS, Toivonen L, Viitasalo M, Wachtell K, Papademetriou V, et al. Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan Intervention for Endpoint Reduction (LIFE) study. Am Heart J. 2003;145(5):919–25.
Marfella R, Gualdiero P, Siniscalchi M, Carusone C, Verza M, Marzano S, et al. Morning blood pressure peak, QT intervals, and sympathetic activity in hypertensive patients. Hypertension. 2003;41(2):237–43.
Giunti S, Bruno G, Lillaz E, Gruden G, Lolli V, Chaturvedi N, et al. Incidence and risk factors of prolonged QTc interval in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care. 2007;30(8):2057–63.
Griffin M, Lee HW, Zhao L, Eghbali-Webb M. Gender-related differences in proliferative response of cardiac fibroblasts to hypoxia. Mol Cell Biochem. 2000;215(1-2):21–30.
Montanez A, Ruskin JN, Hebert PR, Lamas GA, Hennekens CH. Prolonged QTc interval and risks of total and cardiovascular mortality and sudden death in the general population: a review and qualitative overview of the prospective cohort studies. Arch Intern Med. 2004;164(9):943–8.
Acknowledgment
We thank the study participants, the staff, and management of the Mbarara Regional Referral Hospital who contributed in several ways towards the success of this study. We are very thankful to members of the Technical Advisory Committee (TAC) of the Mbarara University Research Training Initiative (MURTI) for their technical input into the study. We also acknowledge Dr. Sam Ruvuma and Dr. Kwagga Teddy of the Ophthalmology Department of the Mbarara University of Science and Technology for their technical support.
Availability of data and materials
The datasets generated and analyzed during the study are available from the corresponding author on request.
Funding
This research was supported by the Fogarty International Center and co-founding partners (NIH Common Fund, Office of Strategic Coordination, Office of the Director (OD/OSC/CF/NIH); Office of AIDS Research, Office of the Director (OAR/NIH); National Institute of Mental Health (NIMH/NIH); and National Institute of Neurological Disorders and Stroke (NINDS/NIH)) of the National Institutes of Health under Award Number D43TW010128.
Author information
Authors and Affiliations
Contributions
R.M., A.M., D.C.A, S.L.M, and M.S conceived the study, contributed to discussion, and reviewed, edited, and wrote the manuscript. G.K. and D.C.A. reviewed the ECG recordings. R.M and M.S. analyzed the data. R.M. is the guarantor of this research work and, as such, had full access to all the data for the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The study got an approval from the institutional ethics review board of the Mbarara University of Science and Technology (MUST-REC). We also received approval for the study from the Uganda National Council of Science and Technology (UNCST) and from the Research Secretariat in the Office of the President of Uganda, in accordance with the national guidelines. All study participants provided written informed consent before recruitment and participation. Participants who could not write gave consent with a thumbprint.
Conflict of interests
The authors declare no competing interests.
Disclaimer
The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Migisha, R., Agaba, D.C., Katamba, G. et al. High prevalence of prolonged QTc interval among individuals in ambulatory diabetic care in southwestern Uganda. Int J Diabetes Dev Ctries 41, 614–620 (2021). https://doi.org/10.1007/s13410-021-00944-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13410-021-00944-6